Cargando…

Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease

Chronic lymphocytic leukaemia (CLL) is characterised by the expansion of a neoplastic mature B cell clone. CLL clinical outcome is very heterogeneous, with some subjects never requiring therapy and some showing an aggressive disease. Genetic and epigenetic alterations and pro-inflammatory microenvir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rubino, Valentina, Carriero, Flavia, Palatucci, Anna Teresa, Giovazzino, Angela, Leone, Stefania, Nicolella, Valerio, Calabrò, Martina, Montanaro, Rosangela, Brancaleone, Vincenzo, Pane, Fabrizio, Chiurazzi, Federico, Ruggiero, Giuseppina, Terrazzano, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253385/ https://www.ncbi.nlm.nih.gov/pubmed/37298547 http://dx.doi.org/10.3390/ijms24119596

Ejemplares similares

Bone marrow CD3 (+) CD56 (+) regulatory T lymphocytes (T(R3) (−56) cells) are inversely associated with activation and expansion of bone marrow cytotoxic T cells in IPSS‐R very‐low/low risk MDS patients
por: Leone, Stefania, et al.
Publicado: (2022)

An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?
por: Terrazzano, Giuseppe, et al.
Publicado: (2020)

Superoxide Dismutase-1 Intracellular Content in T Lymphocytes Associates with Increased Regulatory T Cell Level in Multiple Sclerosis Subjects Undergoing Immune-Modulating Treatment
por: Rubino, Valentina, et al.
Publicado: (2021)

Effect of a Weight Loss Program on Biochemical and Immunological Profile, Serum Leptin Levels, and Cardiovascular Parameters in Obese Dogs
por: Piantedosi, Diego, et al.
Publicado: (2020)

P711: THE PREVALENCE OF FOXP3-E2 ISOFORM IN REGULATORY T CELLS CORRELATES WITH THE DEGREE OF DYSPLASIA IN MYELODYSPLASTIC SYNDROMES
por: Leone, Stefania, et al.
Publicado: (2023)

Toxicological Implications and Inflammatory Response in Human Lymphocytes Challenged with Oxytetracycline
por: Di Cerbo, A., et al.
Publicado: (2015)

Pro-Inflammatory and Immunological Profile of Dogs with Myxomatous Mitral Valve Disease
por: Piantedosi, Diego, et al.
Publicado: (2022)

In Vitro Effects of Some Botanicals with Anti-Inflammatory and Antitoxic Activity
por: Guidetti, Gianandrea, et al.
Publicado: (2016)

Oxytetracycline induces DNA damage and epigenetic changes: a possible risk for human and animal health?
por: Gallo, Adriana, et al.
Publicado: (2017)

Clinical and Immunological Response in Dogs Naturally Infected by L. infantum Treated with a Nutritional Supplement
por: Lombardi, Pietro, et al.
Publicado: (2019)

T1D progression is associated with loss of CD3(+)CD56(+) regulatory T cells that control CD8(+) T cell effector functions
por: Terrazzano, Giuseppe, et al.
Publicado: (2020)

Insights on the Multifaceted Roles of Wild-Type and Mutated Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis Pathogenesis
por: Rubino, Valentina, et al.
Publicado: (2023)

Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
por: Freeman, Ciara L., et al.
Publicado: (2016)

Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment
por: Ercolano, Giuseppe, et al.
Publicado: (2019)

Hydrogen sulfide donor AP123 restores endothelial nitric oxide-dependent vascular function in hyperglycemia via a CREB-dependent pathway
por: Montanaro, Rosangela, et al.
Publicado: (2023)

The Mysterious Actor—γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL)
por: Zarobkiewicz, Michał K., et al.
Publicado: (2022)

The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience
por: Van Dyke, Daniel L., et al.
Publicado: (2016)

Modulation of EndMT by Hydrogen Sulfide in the Prevention of Cardiovascular Fibrosis
por: Testai, Lara, et al.
Publicado: (2021)

In vitro evidence for the involvement of H(2)S pathway in the effect of clodronate during inflammatory response
por: Montanaro, Rosangela, et al.
Publicado: (2021)

Cytotoxic effects of oxytetracycline residues in the bones of broiler chickens following therapeutic oral administration of a water formulation
por: Odore, R., et al.
Publicado: (2015)

Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL
por: Collins, McKensie A., et al.
Publicado: (2022)

Use of larvae of the wax moth Galleria mellonella as an in vivo model to study the virulence of Helicobacter pylori
por: Giannouli, Maria, et al.
Publicado: (2014)

Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of CTLA-4 expression on CLL cells: the possible implications for immunotherapy with CTLA-4 blocking antibody
por: Ciszak, Lidia, et al.
Publicado: (2015)

NK cells blur the frontier between innate and acquired immunity
por: Terrazzano, Giuseppe, et al.
Publicado: (2013)

An immune-modulating diet increases the regulatory T cells and reduces T helper 1 inflammatory response in Leishmaniosis affected dogs treated with standard therapy
por: Cortese, Laura, et al.
Publicado: (2015)

Mechanical phenotyping of K562 cells by the Micropipette Aspiration Technique allows identifying mechanical changes induced by drugs
por: Di Cerbo, Alessandro, et al.
Publicado: (2018)

Fast COVID-19 vaccine effectiveness estimation on the basis of recovered individual propensity to be vaccinated
por: Guerriero, V., et al.
Publicado: (2022)

Shielding the Vulnerable: A Multicentre Australian Rollout of Evusheld to Patients with Chronic Lymphocytic Leukaemia (CLL-SHIELD)
por: Whitechurch, Ashley, et al.
Publicado: (2022)

Anti‐inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H(2)S donors in COVID‐19 therapy
por: Citi, Valentina, et al.
Publicado: (2020)

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
por: Egle, Alexander, et al.
Publicado: (2018)

PB2328: CHRONIC LYMPHATIC LEUKAEMIA (CLL) ASSOCIATED TO ACQUIRED FACTOR V INHIBITOR. A CASE REPORT.
por: Porro Camarero, A., et al.
Publicado: (2022)

Low Serum Cholesterol Level Is a Significant Prognostic Factor That Improves CLL-IPI in Chronic Lymphocytic Leukaemia
por: Gao, Rui, et al.
Publicado: (2023)

Immune Response to Covid-19 Vaccination in Patients with Chronic Lymphocytic Leukaemia (CLL): An Experience from Two Italian Centres
por: Innocenti, Idanna, et al.
Publicado: (2022)

Innate Immune Effectors in Mycobacterial Infection
por: Saiga, Hiroyuki, et al.
Publicado: (2011)

Neutrophils: Innate Effectors of TB Resistance?
por: Kroon, Elouise E., et al.
Publicado: (2018)

Effector triggered immunity: Activation of innate immunity in metazoans by bacterial effectors
por: Rajamuthiah, Rajmohan, et al.
Publicado: (2014)

CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL?
por: Popov, Viola, et al.
Publicado: (2022)

Clinical evaluation of a nutraceutical diet as an adjuvant to pharmacological treatment in dogs affected by Keratoconjunctivitis sicca
por: Destefanis, Simona, et al.
Publicado: (2016)

Erratum to: Clinical evaluation of a nutraceutical diet as an adjuvant to pharmacological treatment in dogs affected by Keratoconjunctivitis sicca
por: Destefanis, Simona, et al.
Publicado: (2016)

The effectors of innate immunity: DAMPs, DAMEs, or DIMEs?
por: Pisetsky, David S
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l8915heictk0ebrqgu5s7otd5e